Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Take a short survey to help improve our website, find out about how philanthropy supports our research, or meet some of our employees.

World’s largest sarcoma research database aims to revolutionise sarcoma treatment after multi-million pound investment

Researchers are set to begin work on the world’s largest digital hub of sarcoma clinical and research data after receiving a £2.5m grant.
Read more
Let’s finish it: help us revolutionise cancer treatment

We aim to discover a new generation of cancer treatments so smart and targeted, that more patients will defeat their cancer and finish what they started.
Support us
Sign up to our 'Science highlights' newsletter

'Science highlights' provides monthly updates on the ICR’s latest research news and also promotes scientific vacancies.
Subscribe
ICR experts show Discovery Club how to build the cancer drugs of the future

Members of the ICR’s Discovery Club saw first-hand the delicacy and complexity of techniques used to sculpt new drug molecules, as they learned how our scientists design the cancer drugs of the future.
Read more
Scientists identify drug fragments that could lead to new cancer drugs

Researchers have found drug fragments, which could help improve our understanding of the function of a key cancer protein and ultimately lead to new drug treatments.
Read more

1/5

Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more